Game-Changer for Tough Lymphomas?

Just read about a new treatment combo that could seriously boost survival for people with aggressive T- and NK-cell lymphomas. Researchers found that using small-molecule inhibitors first, then epigenetic modifiers, worked way better than old-school chemo for those who relapsed. The difference was especially huge for high-risk patients! It’s wild how switching up the order of meds could make such a big impact. Could this be the new standard for tough-to-treat blood cancers? #CancerResearch #Lymphoma #MedicalBreakthrough #Oncology #HealthNews #Health